PEPTIC ULCER PREVENTION BY ESOMEPRAZOLE 20 MG AND 40 MG ONCE DAILY IN PATIENTS TAKING LOW-DOSE ACETYLSALICYLIC ACID FOR SECONDARY CARDIOVASCULAR PREVENTION

(1) University of Michigan Hospita, Gastroenterology, Ann Arbor, USA

(2) Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska University Hospital, G

(3) Department of Medicine, OsloUniversity Hospital, Oslo, Norway

(4) Department of Medicine, University of Zaragoza, Zaragoza, Spain

(5) University of Alberta, Edmonton, Canada

(6) Statistics and Informatics, AstraZeneca R&D, Mölndal, Sweden

(7) AstraZeneca R&D, Mölndal, Sweden



This item was part of the Dyspepsia, acid peptic disorders, NSAIDS session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A53